Sudarshan Pharma Industries Ltd Sees Technical Momentum Shift Amid Mixed Signals

Price Movement and Market Context

The stock closed at ₹34.35 on 2 June 2026, down 2.00% from the previous close of ₹35.05. Intraday volatility was evident with a low of ₹33.30 and a high of ₹35.88, while the 52-week range remains between ₹18.50 and ₹36.95. This places the current price near the upper end of its annual trading band, signalling a degree of price strength despite the recent pullback.

Comparatively, Sudarshan Pharma has outperformed the broader Sensex index across multiple timeframes. Year-to-date returns stand at 24.68%, significantly ahead of the Sensex’s negative 12.85%. Over one year, the stock has delivered 16.84% returns versus the Sensex’s decline of 8.82%. The three-year performance is particularly notable, with a staggering 415.53% gain compared to the Sensex’s 18.96%, underscoring the stock’s long-term growth trajectory within the specialty chemicals sector.

Technical Trend Evolution

The technical trend for Sudarshan Pharma has shifted from bullish to mildly bullish, reflecting a more cautious outlook among traders and analysts. This change is supported by a blend of weekly and monthly indicator signals that paint a complex picture of momentum and trend strength.

The Moving Average Convergence Divergence (MACD) indicator remains bullish on the weekly chart, suggesting that short-term momentum is still positive. However, the monthly MACD has turned mildly bearish, indicating some weakening in longer-term momentum. This divergence between weekly and monthly MACD readings suggests that while the stock may experience short-term rallies, investors should be mindful of potential headwinds in the medium term.

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of directional bias from RSI implies that the stock is neither overbought nor oversold, providing a balanced backdrop for price action without extreme momentum pressures.

Bollinger Bands and Moving Averages

Bollinger Bands on the weekly chart remain bullish, indicating that price volatility is contained within an upward trending channel. Conversely, the monthly Bollinger Bands show a sideways pattern, reflecting consolidation over a longer horizon. This suggests that while short-term price swings may favour the bulls, the stock is undergoing a period of range-bound trading on a monthly scale.

Daily moving averages continue to support a bullish stance, with the stock price trading above key averages. This alignment typically signals ongoing buying interest and a positive near-term trend. However, the absence of a clear trend in Dow Theory on both weekly and monthly charts indicates that the broader market forces are not decisively influencing the stock’s direction at present.

Additional Technical Indicators

The Know Sure Thing (KST) indicator is mildly bullish on the weekly timeframe, reinforcing the notion of moderate upward momentum. However, the monthly KST reading is not available, limiting the ability to assess longer-term momentum shifts fully. On-Balance Volume (OBV) data is not provided, which would have offered insights into volume-driven price movements.

Mojo Score and Analyst Ratings

Sudarshan Pharma holds a Mojo Score of 64.0, reflecting a moderate technical strength. The Mojo Grade has recently been downgraded from Buy to Hold as of 1 June 2026, signalling a more cautious stance by analysts. This downgrade aligns with the mixed technical signals and the shift to a mildly bullish trend, suggesting that investors should monitor developments closely before committing additional capital.

The company is classified as a micro-cap within the specialty chemicals sector, which often entails higher volatility and risk compared to larger peers. This classification further emphasises the need for careful risk management when considering exposure to Sudarshan Pharma.

Investment Implications and Outlook

Investors should weigh the short-term bullish signals against the more cautious monthly indicators. The weekly MACD and Bollinger Bands suggest potential for upward price movement, but the mildly bearish monthly MACD and sideways Bollinger Bands caution against expecting a strong breakout in the near term.

Given the stock’s strong historical returns relative to the Sensex, Sudarshan Pharma remains an attractive candidate for investors with a higher risk tolerance and a medium to long-term horizon. However, the recent technical downgrade and mixed momentum indicators imply that a period of consolidation or mild correction could be forthcoming.

Market participants may consider monitoring the daily moving averages and weekly MACD for confirmation of renewed bullish momentum. Conversely, a sustained break below key support levels near ₹33 could signal a deeper correction phase.

Summary

Sudarshan Pharma Industries Ltd’s technical landscape is characterised by a nuanced shift from bullish to mildly bullish momentum, with key indicators offering mixed signals. While short-term technicals such as weekly MACD and daily moving averages remain supportive, longer-term monthly indicators suggest caution. The stock’s strong relative performance against the Sensex over multiple periods highlights its growth potential, but the recent downgrade to a Hold rating and micro-cap status underline the importance of prudent investment decisions.

Investors should closely monitor technical developments and price action around critical support and resistance levels to gauge the stock’s next directional move within the specialty chemicals sector.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →